Connection

William Creasman to Uterine Neoplasms

Back to Details
This is a "connection" page, showing publications William Creasman has written about Uterine Neoplasms.
William Creasman
Connection Strength
3.425
Uterine Neoplasms
  1. Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases? Gynecol Oncol. 2016 08; 142(2):278-82.
    View in: PubMed
    Score: 0.530
  2. What is the significance of gynecologic symptoms in the participants in the NSABP study? Am J Obstet Gynecol. 2011 Dec; 205(6):511-2.
    View in: PubMed
    Score: 0.382
  3. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S105-43.
    View in: PubMed
    Score: 0.272
  4. Carcinoma of the corpus uteri. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:79-118.
    View in: PubMed
    Score: 0.220
  5. The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women. Gynecol Oncol. 2021 03; 160(3):660-668.
    View in: PubMed
    Score: 0.182
  6. Synuclein-? in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study. Cancer. 2017 04 01; 123(7):1144-1155.
    View in: PubMed
    Score: 0.137
  7. Limited disease: role of surgery. Semin Oncol. 1994 Feb; 21(1):79-83.
    View in: PubMed
    Score: 0.113
  8. Revision in classification by International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol. 1992 Sep; 167(3):857-8.
    View in: PubMed
    Score: 0.102
  9. Estrogen replacement therapy: is previously treated cancer a contraindication? Obstet Gynecol. 1991 Feb; 77(2):308-12.
    View in: PubMed
    Score: 0.091
  10. Recent advances in endometrial cancer. Semin Surg Oncol. 1990; 6(6):339-42.
    View in: PubMed
    Score: 0.085
  11. Absorbable synthetic mesh (910-polyglactin) intestinal sling to reduce radiation-induced small bowel injury in patients with pelvic malignancies. Gynecol Oncol. 1988 Mar; 29(3):283-9.
    View in: PubMed
    Score: 0.075
  12. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987 Oct 15; 60(8 Suppl):2035-41.
    View in: PubMed
    Score: 0.073
  13. Uterine leiomyomas with retroperitoneal lymph node involvement. South Med J. 1987 Oct; 80(10):1320-2.
    View in: PubMed
    Score: 0.073
  14. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy. Clin Obstet Gynaecol. 1986 Dec; 13(4):751-65.
    View in: PubMed
    Score: 0.068
  15. Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases. Gynecol Oncol. 1985 Jun; 21(2):220-7.
    View in: PubMed
    Score: 0.062
  16. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol. 1985 Apr 01; 151(7):922-32.
    View in: PubMed
    Score: 0.061
  17. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis. Obstet Gynecol. 1983 Jan; 61(1):87-94.
    View in: PubMed
    Score: 0.052
  18. A trial of prophylactic cefamandole in extended gynecologic surgery. Obstet Gynecol. 1982 Mar; 59(3):309-14.
    View in: PubMed
    Score: 0.049
  19. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol. 1981 Dec 15; 141(8):921-9.
    View in: PubMed
    Score: 0.049
  20. Cancer of the endometrium. Curr Probl Cancer. 1980 Aug; 5(2):1-33.
    View in: PubMed
    Score: 0.044
  21. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol. 1980 Mar; 55(3):363-70.
    View in: PubMed
    Score: 0.043
  22. A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma. Am J Obstet Gynecol. 1979 Nov 01; 135(5):647-50.
    View in: PubMed
    Score: 0.042
  23. Stage II carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 1979 Mar; 5(3):323-6.
    View in: PubMed
    Score: 0.040
  24. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet. 1999 Jan; 64(1):5-10.
    View in: PubMed
    Score: 0.040
  25. Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report. Gynecol Oncol. 1976 Sep; 4(3):239-43.
    View in: PubMed
    Score: 0.034
  26. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer. 1993 Feb 15; 71(4 Suppl):1702-9.
    View in: PubMed
    Score: 0.026
  27. Role of the fallopian tube in dissemination of malignant cells in corpus cancer. Cancer. 1972 Feb; 29(2):456-7.
    View in: PubMed
    Score: 0.024
  28. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991 Jan; 40(1):55-65.
    View in: PubMed
    Score: 0.023
  29. Estrogen and progesterone receptor content of endometrial carcinomas: comparison of total tissue versus cancer component analysis. Gynecol Oncol. 1990 Mar; 36(3):363-8.
    View in: PubMed
    Score: 0.021
  30. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. Gynecol Oncol. 1990 Feb; 36(2):166-71.
    View in: PubMed
    Score: 0.021
  31. New gynecologic cancer staging. Obstet Gynecol. 1990 Feb; 75(2):287-8.
    View in: PubMed
    Score: 0.021
  32. Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor. Obstet Gynecol. 1989 May; 73(5 Pt 1):780-5.
    View in: PubMed
    Score: 0.020
  33. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989 Apr; 33(1):68-70.
    View in: PubMed
    Score: 0.020
  34. The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
    View in: PubMed
    Score: 0.019
  35. Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methods. Am J Obstet Gynecol. 1987 Oct; 157(4 Pt 1):924-31.
    View in: PubMed
    Score: 0.018
  36. Histologic composition of endometrial carcinomas analyzed for steroid receptor content. Am J Obstet Gynecol. 1987 Jul; 157(1):26-7.
    View in: PubMed
    Score: 0.018
  37. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986 Oct; 46(10):5419-25.
    View in: PubMed
    Score: 0.017
  38. Prognostic value of peritoneal washings in patients with malignant mixed m?llerian tumors of the uterus. Am J Obstet Gynecol. 1986 Jul; 155(1):83-9.
    View in: PubMed
    Score: 0.017
  39. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol. 1986 Mar; 67(3):326-30.
    View in: PubMed
    Score: 0.016
  40. Superior vena cava syndrome associated with gynecologic malignancy. Gynecol Oncol. 1986 Jan; 23(1):59-64.
    View in: PubMed
    Score: 0.016
  41. Histologic control of biochemical steroid receptor analysis in endometrial carcinomas. Am J Obstet Gynecol. 1985 Nov 01; 153(5):520-3.
    View in: PubMed
    Score: 0.016
  42. Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol. 1985 Sep 15; 153(2):191-6.
    View in: PubMed
    Score: 0.016
  43. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group). Cancer. 1985 Apr 15; 55(8):1648-53.
    View in: PubMed
    Score: 0.015
  44. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985 Apr 15; 151(8):1009-15.
    View in: PubMed
    Score: 0.015
  45. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas. Am J Obstet Gynecol. 1984 Oct 15; 150(4):342-8.
    View in: PubMed
    Score: 0.015
  46. Induction of cytoplasmic progesterone receptor in human endometrial carcinoma transplanted into nude mice. Am J Obstet Gynecol. 1984 Oct 15; 150(4):437-9.
    View in: PubMed
    Score: 0.015
  47. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984 Jun; 63(6):825-32.
    View in: PubMed
    Score: 0.014
  48. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study. Cancer Treat Rep. 1984 May; 68(5):809-11.
    View in: PubMed
    Score: 0.014
  49. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer. 1983 Aug 15; 52(4):626-32.
    View in: PubMed
    Score: 0.014
  50. Intracavitary Corynebacterium parvum for treatment of malignant effusions. Gynecol Oncol. 1983 Aug; 16(1):6-14.
    View in: PubMed
    Score: 0.014
  51. Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma. Acta Cytol. 1981 Nov-Dec; 25(6):640-6.
    View in: PubMed
    Score: 0.012
  52. Risk of exogenous estrogen therapy and endometrial cancer. Am J Obstet Gynecol. 1980 May 01; 137(1):85-91.
    View in: PubMed
    Score: 0.011
  53. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. Am J Pathol. 1979 Jul; 96(1):171-83.
    View in: PubMed
    Score: 0.010
  54. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol. 1979 Mar 01; 133(5):537-47.
    View in: PubMed
    Score: 0.010
  55. Endometrial sarcoma: lymphatic spread pattern. Am J Obstet Gynecol. 1978 Jan 01; 130(1):104-5.
    View in: PubMed
    Score: 0.009
  56. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol. 1971 Jul 15; 110(6):773-81.
    View in: PubMed
    Score: 0.006
  57. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol. 1979 Mar 01; 133(5):525-36.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.